The Decibel

The Globe and Mail
undefined
Apr 29, 2024 • 22min

The biggest EV investment in Canada yet

Adam Radwanski, The Globe's climate policy columnist, discusses Canada's largest EV investments, including Honda's $15 billion plan. They explore the government's push for zero-emission cars by 2030, challenges in the EV industry, and the significance of Honda's move for Canada's future.
undefined
Apr 26, 2024 • 42min

City Space: Vancouver’s Chinatown fights gentrification

Exploring the resilient history of Vancouver's Chinatown, from facing racism and discrimination to battling gentrification. The podcast dives into the cultural significance of Tongue Associations, defensive architecture, and revitalization efforts. It highlights the challenges of changing demographics, business ownership shifts, and the importance of preserving community bonds amidst urban changes.
undefined
Apr 25, 2024 • 22min

The call to disband the Thunder Bay police

Journalist Willow Fiddler discusses the call to disband the Thunder Bay Police Service due to charges, racism, and misconduct. Topics include inadequate investigations, systemic racism, police failures, and efforts to rebuild trust with Indigenous communities.
undefined
Apr 24, 2024 • 20min

How Hong Kong is cracking down on dissent

James Griffiths, The Globe's Asia Correspondent, discusses the new national security law in Hong Kong, known as Article 23, its impact on protests and human rights. The law includes offenses related to sedition, treason, and state secrets, raising concerns about freedom of speech. Griffiths explores the broad reach of the law and the risks faced by journalists in Hong Kong.
undefined
Apr 23, 2024 • 20min

As conflict rages in Gaza, a ‘silent war’ in the West Bank

Exploring the impact of Israeli settlements on West Bank farmlands, termed the 'silent war'. Challenges faced by Palestinian farmers in accessing their land. Consequences on food access and livestock in the region. Escalating tensions between Israeli settlers and Palestinians. Global disapproval and sanctions on Israeli citizens involved in violence.
undefined
Apr 22, 2024 • 20min

The capital gains tax, explained

Salmaan Farooqui, a personal finance reporter with the Globe’s Report on Business, discusses the basics of capital gains tax in Canada and how the recent changes might impact Canadians. The podcast explores the implications for wealthy individuals, middle-class Canadians, small business owners, and the effectiveness of the new tax measures in generating revenue.
undefined
Apr 19, 2024 • 22min

ArriveCan and the government’s outsourcing problem

Kristian Firth, involved in developing ArriveCan app, faced scrutiny for app's $59.5M cost. Outsourcing to GC Strategies questioned. Bill Curry discusses Firth's historic House of Commons appearance. Controversy around app's development, cost escalation, and government spending practices explored.
undefined
Apr 18, 2024 • 19min

The stakes of India’s election as Modi seeks third term

Sanjay Ruparelia, an associate professor at Toronto Metropolitan University, discusses the significance of India's election and Modi's bid for a third term. Topics include Modi's leadership, challenges faced by the opposition, and implications for global relations, including Canada-India ties.
undefined
Apr 17, 2024 • 23min

What the 2024 federal budget means for you

Unveiling the 2024 federal budget's impact on affordability, housing, defense, and tax hikes. Experts analyze funding sources, housing construction criteria, and capital gains tax changes. Government's focus on inflation control, financial fairness, and housing market initiatives.
undefined
Apr 16, 2024 • 22min

How a new kind of drug could change the future of Alzheimer’s

Health reporter Kelly Grant discusses a new drug being tested for Alzheimer's in Canada, offering hope for delaying symptoms. The podcast explores the challenges of diagnosing Alzheimer's, the impact on individuals and society, and the potential of lycanumab in slowing disease progression. With promising results but high costs and risks, the drug raises debates on its effectiveness and impact on Alzheimer's research.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app